DIFFUSIO2N
Dead / Cancelled — Cancelled — Section 8 (as of 29 Jul 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77577940
- Registration number
- 4088239
- Mark type
- Word mark
- Filed
- 24 Sept 2008
- Published for opposition
- 06 Jan 2009
- Registered
- 17 Jan 2012
- Attorney of record
- Michael Tsimaras
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tissue oxygenation that enhance performance of mammals
Owner
- Diffusion Pharmaceuticals LLC, Charlottesville, VA, US
- Diffusion Pharmaceuticals LLC, Charlottesville, VA, US
- Diffusion Pharmaceuticals LLC, Charlottesville, VA, US
Prosecution history
- 29 Jul 2022 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 17 Jan 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 17 Jan 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Jan 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Jan 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Dec 2017 — TEAS SECTION 8 & 15 RECEIVED
- 15 Dec 2017 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Dec 2017 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jan 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jan 2012 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Dec 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 09 Dec 2011 — ASSIGNED TO LIE
- 17 Nov 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Nov 2011 — STATEMENT OF USE PROCESSING COMPLETE